Related Experiment Video
Updated: Jun 23, 2026
11:31
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
Published on: April 2, 2016
A duplex allele-specific amplification PCR to detect SMN1 deletion
Patrícia de Campos Pieri1, Jeronimo de Alencar Nogueira, Maria Joaquina Marques-Dias
1Laboratório de Pediatria Clínica-Lim 36, Instituto da Criança-HCFMUSP, Rua Dr. Eneas de Carvalho Aguiar, São Paulo 05403-900, Brazil. patricia.pieri@icr.usp.br
Genetic Testing and Molecular Biomarkers
|April 22, 2009
Summary
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder. This study presents a simpler, cost-effective PCR method for detecting SMN1 exon 7 deletions, crucial for SMA diagnosis.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Molecular Biology
Background:
- Spinal muscular atrophy (SMA) is a leading genetic cause of childhood mortality.
- It is an autosomal recessive neuromuscular disorder characterized by progressive muscle weakness.
- SMA is linked to deletions in the survival motor neuron (SMN) gene on chromosome 5q13, with two homologous copies: SMN1 and SMN2.
Purpose of the Study:
- To develop a simpler and cost-effective diagnostic method for SMN1 exon 7 deletion.
- To improve the accuracy and accessibility of Spinal Muscular Atrophy (SMA) diagnosis.
Main Methods:
- Allele-specific amplification PCR was developed to detect SMN1 exon 7 deletion.
- This method offers an alternative to existing techniques like RFLP and real-time PCR.
Main Results:
- The developed method provides a simpler and more cost-effective way to identify SMN1 exon 7 deletions.
- This facilitates accurate diagnosis of Spinal Muscular Atrophy (SMA).
Conclusions:
- The allele-specific amplification PCR is a valuable tool for diagnosing SMA.
- This cost-effective method can enhance diagnostic capabilities for this genetic disorder.
